Alexandraki, K.I.; Papadimitriou, E.; Mavroeidi, V.; Kyriakopoulos, G.; Xydakis, A.; Papaioannou, T.G.; Kolomodi, D.; Kaltsas, G.A.; Grossman, A.B.
Role of Receptor Profiling for Personalized Therapy in a Patient with a Growth Hormone-Secreting Macroadenoma Resistant to First-Generation Somatostatin Analogues. J. Pers. Med. 2019, 9, 48.
https://doi.org/10.3390/jpm9040048
AMA Style
Alexandraki KI, Papadimitriou E, Mavroeidi V, Kyriakopoulos G, Xydakis A, Papaioannou TG, Kolomodi D, Kaltsas GA, Grossman AB.
Role of Receptor Profiling for Personalized Therapy in a Patient with a Growth Hormone-Secreting Macroadenoma Resistant to First-Generation Somatostatin Analogues. Journal of Personalized Medicine. 2019; 9(4):48.
https://doi.org/10.3390/jpm9040048
Chicago/Turabian Style
Alexandraki, Krystallenia I., Eirini Papadimitriou, Vasiliki Mavroeidi, Georgios Kyriakopoulos, Antonios Xydakis, Theodoros G. Papaioannou, Denise Kolomodi, Gregory A. Kaltsas, and Ashley B. Grossman.
2019. "Role of Receptor Profiling for Personalized Therapy in a Patient with a Growth Hormone-Secreting Macroadenoma Resistant to First-Generation Somatostatin Analogues" Journal of Personalized Medicine 9, no. 4: 48.
https://doi.org/10.3390/jpm9040048
APA Style
Alexandraki, K. I., Papadimitriou, E., Mavroeidi, V., Kyriakopoulos, G., Xydakis, A., Papaioannou, T. G., Kolomodi, D., Kaltsas, G. A., & Grossman, A. B.
(2019). Role of Receptor Profiling for Personalized Therapy in a Patient with a Growth Hormone-Secreting Macroadenoma Resistant to First-Generation Somatostatin Analogues. Journal of Personalized Medicine, 9(4), 48.
https://doi.org/10.3390/jpm9040048
